Evidence map›Paper›PMID 42626038›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Yuki Oi, Qian Shen, Seraphina K Solders, Charlotte S Rivera, McKenna E Williams, Emilie T Reas

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki OiDepartment of Neurosciences University of California, San Diego La Jolla California USA.
Qian ShenDepartment of Neurosciences University of California, San Diego La Jolla California USA.
Seraphina K SoldersDepartment of Neurosciences University of California, San Diego La Jolla California USA.
Charlotte S RiveraDepartment of Neurosciences University of California, San Diego La Jolla California USA.
McKenna E WilliamsDepartment of Neurosciences University of California, San Diego La Jolla California USA.
Emilie T ReasDepartment of Neurosciences University of California, San Diego La Jolla California USA.

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Steven Dyal Edland · 2019 to 2026
$34.9M
Moderate alcohol use: risk or protective factor for age-related cognitive decline, mild cognitive impairment, and brain health in agingR01AG062483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCEVOY, LINDA KATHLEEN · 2019 to 2021
$1.6M
Association of blood-brain barrier breakdown with brain microstructure neuropathology in early Alzheimer's DiseaseR00AG057797 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REAS, EMILIE T. · 2021 to 2023
$747k
Association of blood-brain barrier breakdown with structural and molecular neuropathology in early Alzheimer's diseaseK99AG057797 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REAS, EMILIE T. · 2019 to 2020
$175k
NIA NIH HHS K99 AG057797NIA NIH HHS P30 AG062429NIA NIH HHS R00 AG057797NIA NIH HHS R01 AG062483
6 · The paper itself

Abstract

Introduction: While the apolipoprotein E ( Methods: We measured BBB permeability ( Results: In Discussion: Our data suggest that WMHs comprise both

Indexed as

Alzheimer's disease riskamyloid betablood–brain barrier leakagecerebral small vessel diseasediffusion magnetic resonance imagingmulti‐modal neuroimaging

Identifiers

PMID42626038
PMCPMC13490850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.